Autopsy report · NCT05168306

T2 FSL2 Weight Loss

“Slow enrollment and Study no longer required”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 7 months before it stopped.
• 43 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Abbott Diabetes Care

Sponsor type

Industry

Conditions

Diabetes Mellitus, Type 2

Interventions

FreeStyle Libre 2 Flash Glucose Monitoring System

Participants

43

Sites

1

Countries

United States

Trials that died the same way

• Study in Adult Subjects Undergoing Posterolateral Thoracotomy
  “Slow study enrollment” (91% match in meaning)
• Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
  “Study stopped due to slow enrollment” (88% match in meaning)
• Feasibility Study: Histological Characterization After Treatment With the Ulthera® System
  “Slow subject enrollment; study to be obtained is no longer required.” (86% match in meaning)
• Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Implant vs. a Bioabsorbable Nasal Dressing
  “Study enrollment was too slow to complete the study in a reasonable time” (85% match in meaning)
• A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy
  “Slow enrollment” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.